Cited by 154Gastrointestinal motility and disordersProbiotics and Fermented FoodsGut microbiota and health

Systematic review: Probiotics in the management of lower gastrointestinal symptoms—An updated evidence-based international consensus

Open access
Hungin, A. P. S., Mitchell, C. R., Whorwell, P., Mulligan, C., Cole, O., Agréus, L., Fracasso, P., Lionis, C. +7 more·2018·Alimentary Pharmacology & Therapeutics

Abstract

BACKGROUND: In 2013, a systematic review and Delphi consensus reported that specific probiotics can benefit adult patients with irritable bowel syndrome (IBS) and other gastrointestinal (GI) problems. AIM: To update the consensus with new evidence. METHODS: A systematic review identified randomised, placebo-controlled trials published between January 2012 and June 2017. Evidence was graded, previously developed statements were reassessed by an 8-expert panel, and agreement was reached via Delphi consensus. RESULTS: A total of 70 studies were included (IBS, 34; diarrhoea associated with antibiotics, 13; diarrhoea associated with Helicobacter pylori eradication therapy, 7; other conditions, 16). Of 15 studies that examined global IBS symptoms as a primary endpoint, 8 reported significant benefits of probiotics vs placebo. Consensus statements with 100% agreement and "high" evidence level indicated that specific probiotics help reduce overall symptom burden and abdominal pain in some patients with IBS and duration/intensity of diarrhoea in patients prescribed antibiotics or H. pylori eradication therapy, and have favourable safety. Statements with 70%-100% agreement and "moderate" evidence indicated that, in some patients with IBS, specific probiotics help reduce bloating/distension and improve bowel movement frequency/consistency. CONCLUSIONS: This updated review indicates that specific probiotics are beneficial in certain lower GI problems, although many of the new publications did not report benefits of probiotics, possibly due to inclusion of new, less efficacious preparations. Specific probiotics can relieve lower GI symptoms in IBS, prevent diarrhoea associated with antibiotics and H. pylori eradication therapy, and show favourable safety. This study will help clinicians recommend/prescribe probiotics for specific symptoms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.14539

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [24]The Critical Appraisal Skills Programme (CASP). CASP randomised controlled trial checklist Oxford, 2014. http://media.wix.com/ugd/dded87_40b9ff0bf53840478331915a8ed8b2fb.pdf (accessed 2017).
  2. [25]National Institute for Health and Care Excellence. Developing NICE guidelines: the manual appendix H, 2015 https://www.nice.org.uk/process/pmg20/resources/developing-nice-guidelines-the-manual-appendix-h-pdf-2549711485 (accessed 2017). 26677490
  3. [39]Chitapanarux T, Thongsawat S, Pisespongsa P, Leerapun A, Kijdamrongthum P. Effect of Bifidobacterium longum on PPI‐based triple therapy for eradication of Helicobacter pylori: a prospective, randomized study. J Gastroenterol Hepatol. 2014; 29: 23.
  4. [72]Ouwehand AC, ten Bruggencate SJ, Schonewille AJ, et al. Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection. Br J Nutr. 2014; 111: 465‐ 473. 23930950

Cited by

Sorted by citations

Authors
Hungin, A. P. S., Mitchell, C. R., Whorwell, P., Mulligan, C., Cole, O., Agréus, L., Fracasso, P., Lionis, C., Mendive, J., Philippart de Foy, J. ‐., Seifert, B., Wensaas, K. ‐., Winchester, C., de Wit, N., & the European Society for Primary Care Gastroenterology
Affiliations
  • Newcastle upon Tyne UK
  • Oxford UK
  • Manchester UK
  • Brighton UK
  • Stockholm Sweden
  • Rome Italy
  • Heraklion Greece
  • Barcelona Spain
  • Brussels Belgium
  • Prague Czech Republic
  • Bergen Norway
  • Utrecht The Netherlands
Corresponding author
Hungin, A. P. S.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2018-02-20
Volume
47
Issue
8
Pages
1054-1070
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2789742979
Cited by
154
References
110
Citations by year
2026: 9 · 2025: 11 · 2024: 20 · 2023: 22 · 2022: 21 · 2021: 22 · 2020: 18 · 2019: 20 · 2018: 11
FWCI
3.16
Type
journal article
Language
en
Open access
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Research Explorer (The University of Manchester) (submittedVersion, cc-by-nc)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
Funders
Danone
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, irritable bowel syndrome, antibiotic-associated diarrhea, H. pylori eradication therapy, lower gastrointestinal symptoms, abdominal pain, bloating, stool frequency, probiotic safety, evidence-based recommendations
MeSH terms
Animals, Diarrhea, Humans, Randomized Controlled Trials as Topic, Helicobacter pylori, Helicobacter Infections, Probiotics, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review